NYSE · SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC · LARGE CAP
HCA Healthcare, Inc. HCA
17 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY5 YEARS OF DIVIDEND GROWTH
Revenue · FY2025
$75.6B
▲ 7.1% vs FY2024
Dividend streak
5 yrs
Raised every year since 2021
EPS · FY25
$28.33
Dividend / sh · FY25
$2.88
Payout · FY25
10%
ROE · FY25
—
Net margin · FY25
9.0%
Dividend coverage
9.8×
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 75.6B
Revenue, FY2025 · full 17-year series below
Revenue
Net income
9 cents of every revenue dollar became profit this year.
Per share
USD 28.33
Diluted EPS, FY2025
EPS
Dividend
Earnings covered the dividend 9.8 times — the rest stayed in the company.
Profitability
—
Return on equity, FY2025
ROE
Operating margin13.0%
Net margin9.0%
Return on assets11.3%
Returned to shareholders
USD 10.7B
returned in FY2025 · dividends + net buybacks
Dividends paidUSD 679.0M
Net buybacksUSD 10.1B
Share of profit158.4%
Consecutive raises5 years
USD 679.0M in dividends and USD 10.1B in buybacks — 158% of the year's profit, so the payout drew on cash built up earlier.
Growth
+8.0% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
+7.9%
+8.0%
+6.8%
Net income
+6.3%
+12.6%
+12.3%
+12.2%
EPS, diluted
+13.9%
+21.0%
+19.0%
+16.8%
Dividend / share
+8.7%
+46.3%
−7.6%
Returned to shareholders
+12.0%
+78.4%
+16.2%
+6.4%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
0.22B
Shares outstanding, FY2025
Change, 5 years−33.8%
Change, 10 years−43.7%
The share count shrank 34% in five years — the same company, cut into fewer, larger slices.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 60.7B
total assets, end of FY2025
Total assetsUSD 60.7B
EquityUSD -6.0B
CashUSD 1.0B
Gross debtUSD 46.5B
Net debtUSD 45.5B
Current ratio0.97×
Net debt stands at -754% of equity.
History
17 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
Revenue $B
75.6
70.6
65.0
60.2
58.8
51.5
51.3
46.7
43.6
41.5
·
36.9
34.2
33.0
29.7
28.0
26.8
Operating income $B
9.8
8.5
7.7
8.6
9.8
5.4
5.2
5.3
4.4
4.8
4.0
3.5
2.9
·
·
·
·
EBITDA $B
13.4
11.8
10.8
11.5
12.7
8.2
7.8
7.6
6.5
6.8
5.9
5.3
4.7
·
·
·
·
Income tax $B
2.0
1.9
1.6
1.7
2.1
1.0
1.1
0.9
1.6
1.4
1.3
1.1
0.9
0.9
0.7
0.7
0.6
Net income $B
6.8
5.8
5.2
5.6
7.0
3.8
3.5
3.8
2.2
2.9
2.1
1.9
1.6
1.6
2.5
1.2
1.1
EPS, diluted $
28.33
22.00
18.97
19.15
21.16
10.93
10.07
10.66
5.95
7.30
4.99
4.16
3.37
3.49
4.97
2.76
2.44
Dividend / sh $
2.88
2.64
2.40
2.24
1.92
0.43
1.60
1.40
·
·
·
·
·
6.50
·
9.43
·
Payout %
10
12
13
12
9
4
16
13
0
·
·
0
1
196
1
353
·
ROE %
·
·
·
·
·
·
·
·
·
·
·
·
·
·
134.4
10.1
·
Shares out B
0.22
0.25
0.27
0.28
0.31
0.34
0.34
0.34
0.35
0.37
0.40
0.42
0.44
0.44
0.44
0.43
·
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
49 of 49
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed